Back to Search
Start Over
Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker.
- Source :
-
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 Dec; Vol. 89, pp. 47-55. Date of Electronic Publication: 2024 Sep 27. - Publication Year :
- 2024
-
Abstract
- The study of brain gyrification may provide useful information on the cytoarchitecture and connectivity of the brain. One of the methods that have been developed to estimate brain gyrification, known as surface ratio (SR), has not yet been studied in schizophrenia. Here we aimed to assess whether SR could provide new insights on the brain structure of schizophrenia patients and the severity of symptoms. We also computed a more established brain gyrification measure, namely absolute mean curvature (AMC). We analyzed 63 magnetic resonance images, 25 from schizophrenia patients with treatment-resistant auditory verbal hallucinations (SCH-H), 18 from schizophrenia patients without hallucinations (SCH-NH), and 20 from healthy controls (HC). The SR measure revealed that SCH-H patients had a more folded orbitofrontal cortex than SCH-NH patients and HC. Gyrification in this region was also negatively associated with positive symptoms, specifically with the delusions and conceptual disorganization items, only in the SCH-H group. Regarding the AMC measure, we identified two areas where HC showed more gyrification than SCH-H patients, but no relationships arose with symptoms. The hypergyrification of the orbitofrontal cortex displayed by SCH-H patients, as captured by the SR measure, suggests aberrant and/or excessive wiring in these patients, which in turn could give rise to auditory verbal hallucinations. Alternatively, we comment on potential compensatory mechanisms that may better explain the negative association between orbitofrontal gyrification and positive symptomatology. The SR measure captured the most relevant differences and associations, making it a promising biomarker in schizophrenia.<br />Competing Interests: Conflicts of interest Dr. Roldán has served as advisor or speaker for the companies Otsuka, Rovi and Angelini (unrelated to the present work). The rest of the authors have nothing to disclose.<br /> (Copyright © 2024. Published by Elsevier B.V.)
- Subjects :
- Humans
Male
Female
Adult
Biomarkers
Middle Aged
Young Adult
Schizophrenia diagnostic imaging
Schizophrenia pathology
Schizophrenia metabolism
Hallucinations diagnostic imaging
Hallucinations pathology
Magnetic Resonance Imaging methods
Prefrontal Cortex diagnostic imaging
Prefrontal Cortex pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1873-7862
- Volume :
- 89
- Database :
- MEDLINE
- Journal :
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 39341083
- Full Text :
- https://doi.org/10.1016/j.euroneuro.2024.09.006